Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma

被引:108
作者
Tokura, Y
Ishihara, S
Tagawa, S
Seo, N
Ohshima, K
Takigawa, M
机构
[1] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan
[2] Kashiwara Municipal Hosp, Sect Pediat, Kashiwara, Japan
[3] Osaka City Univ, Sch Med, Dept Clin Haematol, Osaka 545, Japan
[4] Fukuoka Univ, Sch Med, Dept Pathol, Fukuoka 81401, Japan
关键词
D O I
10.1067/mjd.2001.114751
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Hypersensitivity to mosquito bites or mosquito allergy is a mysterious disorder that has been reported mainly in Japanese patients (at least 58 patients) in the first two decades of life. The skin lesion at bite sites is typically a bulla that develops into necrosis. Patients simultaneously exhibit a high temperature and general malaise and subsequently may experience lymphadenopathy and hepatosplenomegaly. Recent studies have revealed that this mosquito hypersensitivity is associated with chronic Epstein-Barr virus infection and natural killer cell leukemia/lymphoma. The natural killer cell, infected with monoclonal (or oligoclonal) Epstein-Barr virus, seems to be involved in the pathogenesis of the hypersensitivity. Half of the patients reported died of hemophagocytic syndrome (or malignant histiocytosis), granular lymphocyte proliferative disorder, or lymphomas. We propose that this disease, defined as the triad of hypersensitivity to mosquito bites, chronic Epstein-Barr virus infection, and natural killer cell leukemia/lymphoma, is a clinical entity mostly seen in Asians.
引用
收藏
页码:569 / 578
页数:10
相关论文
共 60 条
[1]  
AKAI S, 1983, JPN J DERMATOL, V93, P711
[2]   EPSTEIN-BARR VIRUS-ASSOCIATED LARGE GRANULAR LYMPHOCYTE LEUKEMIA WITH CUTANEOUS INFILTRATION [J].
ASADA, H ;
OKADA, N ;
TEI, H ;
YAMAMURA, T ;
HASHIMOTO, K ;
KONDO, K ;
YAMANISHI, K ;
YOSHIKAWA, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 31 (02) :251-255
[3]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[4]  
BROWN A., 1938, Southern Medical Journal, V31, P590, DOI 10.1097/00007611-193806000-00002
[5]   Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm [J].
Chan, JKC ;
Sin, VC ;
Wong, KF ;
Ng, CS ;
Tsang, WYW ;
Chan, CH ;
Cheung, MMC ;
Lau, WH .
BLOOD, 1997, 89 (12) :4501-4513
[6]   An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face [J].
Cho, KH ;
Kim, CW ;
Lee, DY ;
Sohn, SJ ;
Kim, DW ;
Chung, JH .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (04) :791-796
[7]   Epstein-Barr virus-associated lymphoproliferative eruption with progression to large granular lymphocytic leukaemia [J].
Cho, KH ;
Kim, CW ;
Kwon, OS ;
Yang, SG ;
Park, KC ;
Park, MH ;
Cho, HI ;
Kim, JG .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (03) :426-430
[8]   Aggressive natural killer cell leukemia/lymphoma [J].
Dunkley, S ;
Gibson, J ;
Mackinlay, N ;
Joshua, D .
PATHOLOGY, 1998, 30 (02) :157-159
[9]  
Elenitoba-Johnson KSJ, 1998, MODERN PATHOL, V11, P754
[10]  
HARRIS NL, 1994, BLOOD, V84, P1361